Image Ben Hargreaves Market Access FDA’s treatment of China-developed drugs spurs demands for m... China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline. Digital Sleep tracking and the potential for digital endpoints Sleep and its importance to health is becoming a greater focus of research. Market Access Orphan drugs' financial success raises questions R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any. Digital Could virtual reality become an essential tool for healthcar... The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes. Load more results
Market Access FDA’s treatment of China-developed drugs spurs demands for m... China’s emergence as an R&D powerhouse means that the country is quickly adding a number of drug candidates to the global pipeline.
Digital Sleep tracking and the potential for digital endpoints Sleep and its importance to health is becoming a greater focus of research.
Market Access Orphan drugs' financial success raises questions R&D into orphan drugs is growing alongside the number of approved treatments, providing treatments for rare diseases that previously did not have any.
Digital Could virtual reality become an essential tool for healthcar... The technology behind virtual reality is rapidly advancing, allowing developers to create entire 3D hospitals for training purposes.
Sales & Marketing Biotech is back, with Craig Ackerman In Philadelphia this month, pharmaphorum spoke with Craig Ackerman, a partner at the Alexander Group, about launches, AI best practices, and more.
Sales & Marketing Sponsored Using AI-driven synthetic personas to take your insights fur... As AI continues to reshape the healthcare landscape, pharma teams are beginning to leverage synthetic personas.
